🇫🇷 France Country × Condition
non small cell lung cancer Clinical Trials in France
Active clinical trials for non small cell lung cancer with research sites in France. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 8 // Recruiting: 8 Phases: Phase 1, Phase 1, Phase 2 // Updated: Daily
Total Trials
8
Recruiting Now
8
Country
🇫🇷 France
Active Trials in France (8)
NCT07094204 Phase 1
Recruiting
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Enrollment
364 pts
Country
🇫🇷 France
Astellas Pharma Inc
View Trial → NCT07608835
Recruiting
IMMUNO-LUNG : Identification of Biomarkers and Therapeutic Targets for Pulmonary Immunotherapy
Enrollment
200 pts
Country
🇫🇷 France
Institut Paoli-Calmettes
View Trial → NCT06448572 Phase 1, Phase 2
Recruiting
EXL01 in Combination With Nivolumab for Advanced NSCLC Refractory to Immunotherapy.
Enrollment
21 pts
Country
🇫🇷 France
University Hospital, Lille
View Trial → NCT05742607 Phase 2
Recruiting
IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)
Enrollment
70 pts
Country
🇫🇷 France
Innate Pharma
View Trial → NCT04585750 Phase 1, Phase 2
Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Enrollment
300 pts
Country
🇫🇷 France
PMV Pharmaceuticals, Inc
View Trial → NCT06465329 Phase 2
Recruiting
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Enrollment
120 pts
Country
🇫🇷 France
Regeneron Pharmaceuticals
View Trial → NCT07563205
Recruiting
Observational Multicenter Study in Patients Receiving Chemotherapy and Amivantamab for Metastatic Non-small Cell Lung Cancer
Enrollment
100 pts
Country
🇫🇷 France
GFPC Investigation
View Trial → NCT06053099
Recruiting
A Prospective Cohort Study to Evaluate Molecular pRognostic Factors and Resistance Mechanisms to Osimertinib in Adjuvant Treatment of Completely Resected pIB-IIIA Non-small Cell Lung Carcinoma With Common EGFR Mutations (L858R and Del19)
Enrollment
300 pts
Country
🇫🇷 France
Intergroupe Francophone de Cancerol...
View Trial → Frequently Asked Questions
How many non small cell lung cancer clinical trials are active in France?
There are currently 8 active clinical trials for non small cell lung cancer with sites in France, of which 8 are actively recruiting patients.
How can I join a non small cell lung cancer clinical trial in France?
To join a non small cell lung cancer clinical trial in France, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in France directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are non small cell lung cancer trials in France?
Active non small cell lung cancer trials in France span Phase 1, Phase 1, Phase 2, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology